Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-19-2926
Abstract: Through metabolic subtyping, metabolic vulnerabilities can be exploited for developing efficacious treatments. A glycolytic subtype indicates poor survival in patients with pancreatic cancer, whereas a cholesterogenic subtype correlates with better outcomes potentially due to more… read more here.
Keywords: metabolic subtyping; novel personalized; cancer; personalized therapies ... See more keywords